Xoma reported $0 in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US USD 1.06M 0
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Eli Lilly And LLY:US USD 14.14B 548.2M
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
Life Technologies LIFE:US USD 618K 320K
Novartis NOVN:VX USD 21.24B 2.55B
Regeneron Pharmaceuticals REGN:US USD 2.7B 400K
Teva Pharmaceutical Industries TEVA:US USD 18.5B 1.87B
YTE INCY:US USD 30.48M 681K